Murio E - Search Results

1

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients.

Gavaldà J, de Otero J, Murio E, Vargas V, Rosselló J, Calicó I, Margarit C, Pahissa A. Gavaldà J, et al. Among authors: murio e. Transpl Int. 1997;10(6):462-5. doi: 10.1007/s001470050087. Transpl Int. 1997. PMID: 9428121 Clinical Trial.

2

Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?

Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E, Lázaro JL, Bilbao I, Margarit C. Charco R, et al. Among authors: murio e. Transpl Int. 1996;9 Suppl 1:S195-7. doi: 10.1007/978-3-662-00818-8_49. Transpl Int. 1996. PMID: 8959825

3

Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation.

de Otero J, Gavaldà J, Murio E, Vargas V, Calicó I, Llopart L, Rosselló J, Margarit C, Pahissa A. de Otero J, et al. Among authors: murio e. Clin Infect Dis. 1998 Apr;26(4):865-70. doi: 10.1086/513949. Clin Infect Dis. 1998. PMID: 9564465

4

Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.

Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C. Charco R, et al. Among authors: murio e. Liver Transpl Surg. 1999 May;5(3):204-8. doi: 10.1002/lt.500050303. Liver Transpl Surg. 1999. PMID: 10226111 Free article.

5

Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.

Charco R, Vargas V, Balsells J, Lázaro JL, Murio E, Jaurrieta E, Martorell J, Margarit C. Charco R, et al. Among authors: murio e. J Hepatol. 1996 Apr;24(4):452-9. doi: 10.1016/s0168-8278(96)80166-8. J Hepatol. 1996. PMID: 8738732

6

Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants.

Charco R, Vargas V, Balsells J, Lázaro JL, Murio E, Jaurrieta E, Martorell J, Margarit C. Charco R, et al. Among authors: murio e. Transplant Proc. 1997 Feb-Mar;29(1-2):461-2. doi: 10.1016/s0041-1345(96)00202-3. Transplant Proc. 1997. PMID: 9123082 No abstract available.

7

Risk factors for acute renal failure requiring dialysis after liver transplantation.

Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C. Bilbao I, et al. Among authors: murio e. Clin Transplant. 1998 Apr;12(2):123-9. Clin Transplant. 1998. PMID: 9575400

8

Experience with neoral cyclosporine through the oral route in liver transplantation.

Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C. Bilbao I, et al. Among authors: murio e. Transplant Proc. 1998 Jun;30(4):1432-4. doi: 10.1016/s0041-1345(98)00303-0. Transplant Proc. 1998. PMID: 9636580 Clinical Trial. No abstract available.

9

Cross-clamping of the three hepatic veins in the piggyback technique is a safe and well tolerated procedure.

Margarit C, Lázaro JL, Hidalgo E, Balsells J, Murio E, Charco R, Revhaug A, Mora A, Cortés C. Margarit C, et al. Among authors: murio e. Transpl Int. 1998;11 Suppl 1:S248-50. doi: 10.1007/s001470050471. Transpl Int. 1998. PMID: 9664989 Clinical Trial.

10

Biliary complications secondary to late hepatic artery thrombosis in adult liver transplant patients.

Margarit C, Hidalgo E, Lázaro JL, Murio E, Charco R, Balsells J. Margarit C, et al. Among authors: murio e. Transpl Int. 1998;11 Suppl 1:S251-4. doi: 10.1007/s001470050472. Transpl Int. 1998. PMID: 9664990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters